How should serum C‑reactive protein (CRP) be measured, interpreted, and managed in a pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

C-Reactive Protein (CRP) in Pregnancy

In pregnant patients, CRP should be measured using high-sensitivity assays with pregnancy-specific reference intervals (upper limit 19-20 mg/L), interpreted in combination with clinical assessment and other markers rather than in isolation, and used primarily for diagnosing infection-related complications such as chorioamnionitis, with serial measurements being more informative than single values.

Measurement and Reference Intervals

How to Measure CRP in Pregnancy

  • Use high-sensitivity CRP assays with results expressed in mg/L to one decimal point 1
  • Obtain serial measurements rather than relying on single values, as trends are more predictive of infection than isolated elevated results 2
  • CRP can be measured fasting or non-fasting in metabolically stable patients 1

Pregnancy-Specific Reference Intervals

  • The upper limit of normal in pregnancy is 19-20 mg/L, substantially higher than non-pregnant populations 3, 2
  • CRP levels remain relatively stable across all three trimesters, with no significant variation by gestational age 3, 2
  • If CRP exceeds 10 mg/L, repeat testing and examine for sources of infection or inflammation 1
  • The 95th percentile for healthy pregnant women is approximately 19 mg/L 3

Factors Affecting CRP in Pregnancy

  • Body mass index (BMI) significantly influences CRP levels, with linear increases as BMI rises 3, 4
  • Prepregnancy obesity is associated with more pronounced CRP elevation throughout pregnancy 4
  • Parity positively correlates with CRP concentrations 4
  • Dietary glycemic load shows negative association with CRP levels 4

Clinical Interpretation and Management

Diagnosing Chorioamnionitis in PPROM

CRP must be used as part of a multimodal assessment, never in isolation 5:

  • Combine CRP with clinical assessment (pulse, blood pressure, temperature, symptoms including lower abdominal pain, abnormal vaginal discharge, fever, malaise, reduced fetal movements) 5
  • Include white blood cell count (noting that WBC rises 24 hours after corticosteroid administration and returns to baseline after 3 days) 5
  • Incorporate fetal heart rate monitoring using cardiotocography 5

Diagnostic Performance for Infection

  • For chorioamnionitis diagnosis, CRP ≥8 mg/L has:

    • Sensitivity: 67.7-74.1% 3, 6
    • Specificity: 63.3-77.1% 5, 6
    • Negative predictive value: 92.4-94.6% (excellent for ruling out infection) 3, 6
    • Positive predictive value: 17.2-32.8% 6
  • CRP <8 mg/L has excellent negative predictive value for excluding funisitis and early-onset neonatal sepsis, making it useful for identifying low-risk patients 6

Monitoring Protocols

For inpatient management of PPROM 5:

  • Record vital signs on obstetric early warning charts
  • Monitor for clinical symptoms and signs of infection continuously
  • Measure CRP and WBC as part of infection surveillance

For outpatient management of PPROM 5:

  • Review regularly (1-2 times weekly) in day care unit, maternity triage, or antenatal ward
  • Include blood tests (WBC and CRP), clinical recordings, and fetal heart rate monitoring at each visit
  • Advise immediate hospital attendance if any concerning symptoms develop

Specific Clinical Scenarios

COVID-19 in pregnancy 7:

  • CRP ≥1.28 mg/dL (12.8 mg/L) on days 4-6 after symptom onset predicts need for medical intervention with 81% sensitivity and 100% specificity
  • Persistent fever (≥37.5°C) on days 4-6 after onset strongly correlates with need for intervention (86.4% required treatment)

Early-onset neonatal sepsis prediction 6:

  • Maternal CRP measured up to 72 hours before delivery independently predicts funisitis and early-onset neonatal sepsis
  • Elevated CRP (≥8 mg/L) remains significant even after adjusting for gestational age

Important Caveats

When Results Are Discordant

  • If clinical assessment and laboratory tests are inconsistent, continue observation and repeat testing rather than making immediate management decisions 5
  • Serial measurements showing rising trends are more clinically significant than single elevated values 2

Limitations to Recognize

  • CRP has only 68.7% sensitivity for histological chorioamnionitis, so normal levels do not definitively exclude infection 5
  • CRP does not cross the placental barrier, making it useful for maternal but not direct fetal infection assessment 2
  • Other inflammatory conditions (inflammatory bowel disease, rheumatoid arthritis) may cause mildly to moderately elevated CRP 1

Corticosteroid Interference

  • White blood cell count rises 24 hours after corticosteroid administration and returns to baseline 3 days later, which must be considered when interpreting infection markers 5
  • CRP interpretation is less affected by corticosteroids than WBC count

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.